Rigel Pharma (RIGL) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 50.56 +1.70 (3.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.86 | 52 Week High | $4.38 | |||
| Open | $50.57 | 52 Week Low | $1.88 | |||
| Day High | $50.88 | P/E | N/A | |||
| Day Low | $49.23 | EPS | $-1.12 | |||
| Volume | 31,999 | |||||
